0
     

Report Added
Report already added
Immunotherapy Market - Global Outlook and Forecast 2022-2028

Immunotherapy Market - Global Outlook and Forecast 2022-2028

This report contains market size and forecasts of Immunotherapy in global, including the following market information:

Global Immunotherapy Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Immunotherapy Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Immunotherapy companies in 2021 (%)
The global Immunotherapy market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Monoclonal Antibodies Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Immunotherapy include Abbvie, Amgen, Inc., Biogen, Bristol-Myers Squibb, Celgene, Johnson & Johnson, Merck, Novartis and Pfizer and etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Immunotherapy manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:
Global Immunotherapy Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Immunotherapy Market Segment Percentages, by Type, 2021 (%)
Monoclonal Antibodies
Therapeutic Vaccines
Checkpoint Inhibitors
Non-Specific Immunotherapy
Global Immunotherapy Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Immunotherapy Market Segment Percentages, by Application, 2021 (%)
Oncology
Inflammation
Central Nervous System
Others
Global Immunotherapy Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Immunotherapy Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa

Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Immunotherapy revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Immunotherapy revenues share in global market, 2021 (%)
Key companies Immunotherapy sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Immunotherapy sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Abbvie
Amgen, Inc.
Biogen
Bristol-Myers Squibb
Celgene
Johnson & Johnson
Merck
Novartis
Pfizer
Roche
Table of Contents

1 Introduction to Research & Analysis Reports
1.1 Immunotherapy Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Immunotherapy Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Immunotherapy Overall Market Size
2.1 Global Immunotherapy Market Size: 2021 VS 2028
2.2 Global Immunotherapy Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Immunotherapy Sales: 2017-2028
3 Company Landscape
3.1 Top Immunotherapy Players in Global Market
3.2 Top Global Immunotherapy Companies Ranked by Revenue
3.3 Global Immunotherapy Revenue by Companies
3.4 Global Immunotherapy Sales by Companies
3.5 Global Immunotherapy Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Immunotherapy Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Immunotherapy Product Type
3.8 Tier 1, Tier 2 and Tier 3 Immunotherapy Players in Global Market
3.8.1 List of Global Tier 1 Immunotherapy Companies
3.8.2 List of Global Tier 2 and Tier 3 Immunotherapy Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Immunotherapy Market Size Markets, 2021 & 2028
4.1.2 Monoclonal Antibodies
4.1.3 Therapeutic Vaccines
4.1.4 Checkpoint Inhibitors
4.1.5 Non-Specific Immunotherapy
4.2 By Type - Global Immunotherapy Revenue & Forecasts
4.2.1 By Type - Global Immunotherapy Revenue, 2017-2022
4.2.2 By Type - Global Immunotherapy Revenue, 2023-2028
4.2.3 By Type - Global Immunotherapy Revenue Market Share, 2017-2028
4.3 By Type - Global Immunotherapy Sales & Forecasts
4.3.1 By Type - Global Immunotherapy Sales, 2017-2022
4.3.2 By Type - Global Immunotherapy Sales, 2023-2028
4.3.3 By Type - Global Immunotherapy Sales Market Share, 2017-2028
4.4 By Type - Global Immunotherapy Price (Manufacturers Selling Prices), 2017-2028
5 Sights By Application
5.1 Overview
5.1.1 By Application - Global Immunotherapy Market Size, 2021 & 2028
5.1.2 Oncology
5.1.3 Inflammation
5.1.4 Central Nervous System
5.1.5 Others
5.2 By Application - Global Immunotherapy Revenue & Forecasts
5.2.1 By Application - Global Immunotherapy Revenue, 2017-2022
5.2.2 By Application - Global Immunotherapy Revenue, 2023-2028
5.2.3 By Application - Global Immunotherapy Revenue Market Share, 2017-2028
5.3 By Application - Global Immunotherapy Sales & Forecasts
5.3.1 By Application - Global Immunotherapy Sales, 2017-2022
5.3.2 By Application - Global Immunotherapy Sales, 2023-2028
5.3.3 By Application - Global Immunotherapy Sales Market Share, 2017-2028
5.4 By Application - Global Immunotherapy Price (Manufacturers Selling Prices), 2017-2028
6 Sights by Region
6.1 By Region - Global Immunotherapy Market Size, 2021 & 2028
6.2 By Region - Global Immunotherapy Revenue & Forecasts
6.2.1 By Region - Global Immunotherapy Revenue, 2017-2022
6.2.2 By Region - Global Immunotherapy Revenue, 2023-2028
6.2.3 By Region - Global Immunotherapy Revenue Market Share, 2017-2028
6.3 By Region - Global Immunotherapy Sales & Forecasts
6.3.1 By Region - Global Immunotherapy Sales, 2017-2022
6.3.2 By Region - Global Immunotherapy Sales, 2023-2028
6.3.3 By Region - Global Immunotherapy Sales Market Share, 2017-2028
6.4 North America
6.4.1 By Country - North America Immunotherapy Revenue, 2017-2028
6.4.2 By Country - North America Immunotherapy Sales, 2017-2028
6.4.3 US Immunotherapy Market Size, 2017-2028
6.4.4 Canada Immunotherapy Market Size, 2017-2028
6.4.5 Mexico Immunotherapy Market Size, 2017-2028
6.5 Europe
6.5.1 By Country - Europe Immunotherapy Revenue, 2017-2028
6.5.2 By Country - Europe Immunotherapy Sales, 2017-2028
6.5.3 Germany Immunotherapy Market Size, 2017-2028
6.5.4 France Immunotherapy Market Size, 2017-2028
6.5.5 U.K. Immunotherapy Market Size, 2017-2028
6.5.6 Italy Immunotherapy Market Size, 2017-2028
6.5.7 Russia Immunotherapy Market Size, 2017-2028
6.5.8 Nordic Countries Immunotherapy Market Size, 2017-2028
6.5.9 Benelux Immunotherapy Market Size, 2017-2028
6.6 Asia
6.6.1 By Region - Asia Immunotherapy Revenue, 2017-2028
6.6.2 By Region - Asia Immunotherapy Sales, 2017-2028
6.6.3 China Immunotherapy Market Size, 2017-2028
6.6.4 Japan Immunotherapy Market Size, 2017-2028
6.6.5 South Korea Immunotherapy Market Size, 2017-2028
6.6.6 Southeast Asia Immunotherapy Market Size, 2017-2028
6.6.7 India Immunotherapy Market Size, 2017-2028
6.7 South America
6.7.1 By Country - South America Immunotherapy Revenue, 2017-2028
6.7.2 By Country - South America Immunotherapy Sales, 2017-2028
6.7.3 Brazil Immunotherapy Market Size, 2017-2028
6.7.4 Argentina Immunotherapy Market Size, 2017-2028
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Immunotherapy Revenue, 2017-2028
6.8.2 By Country - Middle East & Africa Immunotherapy Sales, 2017-2028
6.8.3 Turkey Immunotherapy Market Size, 2017-2028
6.8.4 Israel Immunotherapy Market Size, 2017-2028
6.8.5 Saudi Arabia Immunotherapy Market Size, 2017-2028
6.8.6 UAE Immunotherapy Market Size, 2017-2028
7 Manufacturers & Brands Profiles
7.1 Abbvie
7.1.1 Abbvie Corporate Summary
7.1.2 Abbvie Business Overview
7.1.3 Abbvie Immunotherapy Major Product Offerings
7.1.4 Abbvie Immunotherapy Sales and Revenue in Global (2017-2022)
7.1.5 Abbvie Key News
7.2 Amgen, Inc.
7.2.1 Amgen, Inc. Corporate Summary
7.2.2 Amgen, Inc. Business Overview
7.2.3 Amgen, Inc. Immunotherapy Major Product Offerings
7.2.4 Amgen, Inc. Immunotherapy Sales and Revenue in Global (2017-2022)
7.2.5 Amgen, Inc. Key News
7.3 Biogen
7.3.1 Biogen Corporate Summary
7.3.2 Biogen Business Overview
7.3.3 Biogen Immunotherapy Major Product Offerings
7.3.4 Biogen Immunotherapy Sales and Revenue in Global (2017-2022)
7.3.5 Biogen Key News
7.4 Bristol-Myers Squibb
7.4.1 Bristol-Myers Squibb Corporate Summary
7.4.2 Bristol-Myers Squibb Business Overview
7.4.3 Bristol-Myers Squibb Immunotherapy Major Product Offerings
7.4.4 Bristol-Myers Squibb Immunotherapy Sales and Revenue in Global (2017-2022)
7.4.5 Bristol-Myers Squibb Key News
7.5 Celgene
7.5.1 Celgene Corporate Summary
7.5.2 Celgene Business Overview
7.5.3 Celgene Immunotherapy Major Product Offerings
7.5.4 Celgene Immunotherapy Sales and Revenue in Global (2017-2022)
7.5.5 Celgene Key News
7.6 Johnson & Johnson
7.6.1 Johnson & Johnson Corporate Summary
7.6.2 Johnson & Johnson Business Overview
7.6.3 Johnson & Johnson Immunotherapy Major Product Offerings
7.6.4 Johnson & Johnson Immunotherapy Sales and Revenue in Global (2017-2022)
7.6.5 Johnson & Johnson Key News
7.7 Merck
7.7.1 Merck Corporate Summary
7.7.2 Merck Business Overview
7.7.3 Merck Immunotherapy Major Product Offerings
7.7.4 Merck Immunotherapy Sales and Revenue in Global (2017-2022)
7.7.5 Merck Key News
7.8 Novartis
7.8.1 Novartis Corporate Summary
7.8.2 Novartis Business Overview
7.8.3 Novartis Immunotherapy Major Product Offerings
7.8.4 Novartis Immunotherapy Sales and Revenue in Global (2017-2022)
7.8.5 Novartis Key News
7.9 Pfizer
7.9.1 Pfizer Corporate Summary
7.9.2 Pfizer Business Overview
7.9.3 Pfizer Immunotherapy Major Product Offerings
7.9.4 Pfizer Immunotherapy Sales and Revenue in Global (2017-2022)
7.9.5 Pfizer Key News
7.10 Roche
7.10.1 Roche Corporate Summary
7.10.2 Roche Business Overview
7.10.3 Roche Immunotherapy Major Product Offerings
7.10.4 Roche Immunotherapy Sales and Revenue in Global (2017-2022)
7.10.5 Roche Key News
8 Global Immunotherapy Production Capacity, Analysis
8.1 Global Immunotherapy Production Capacity, 2017-2028
8.2 Immunotherapy Production Capacity of Key Manufacturers in Global Market
8.3 Global Immunotherapy Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Immunotherapy Supply Chain Analysis
10.1 Immunotherapy Industry Value Chain
10.2 Immunotherapy Upstream Market
10.3 Immunotherapy Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Immunotherapy Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List of Tables
Table 1. Key Players of Immunotherapy in Global Market
Table 2. Top Immunotherapy Players in Global Market, Ranking by Revenue (2021)
Table 3. Global Immunotherapy Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global Immunotherapy Revenue Share by Companies, 2017-2022
Table 5. Global Immunotherapy Sales by Companies, (K Units), 2017-2022
Table 6. Global Immunotherapy Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers Immunotherapy Price (2017-2022) & (US$/Unit)
Table 8. Global Manufacturers Immunotherapy Product Type
Table 9. List of Global Tier 1 Immunotherapy Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Immunotherapy Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Immunotherapy Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global Immunotherapy Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global Immunotherapy Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global Immunotherapy Sales (K Units), 2017-2022
Table 15. By Type - Global Immunotherapy Sales (K Units), 2023-2028
Table 16. By Application – Global Immunotherapy Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global Immunotherapy Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global Immunotherapy Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global Immunotherapy Sales (K Units), 2017-2022
Table 20. By Application - Global Immunotherapy Sales (K Units), 2023-2028
Table 21. By Region – Global Immunotherapy Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global Immunotherapy Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global Immunotherapy Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global Immunotherapy Sales (K Units), 2017-2022
Table 25. By Region - Global Immunotherapy Sales (K Units), 2023-2028
Table 26. By Country - North America Immunotherapy Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America Immunotherapy Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America Immunotherapy Sales, (K Units), 2017-2022
Table 29. By Country - North America Immunotherapy Sales, (K Units), 2023-2028
Table 30. By Country - Europe Immunotherapy Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe Immunotherapy Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe Immunotherapy Sales, (K Units), 2017-2022
Table 33. By Country - Europe Immunotherapy Sales, (K Units), 2023-2028
Table 34. By Region - Asia Immunotherapy Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia Immunotherapy Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia Immunotherapy Sales, (K Units), 2017-2022
Table 37. By Region - Asia Immunotherapy Sales, (K Units), 2023-2028
Table 38. By Country - South America Immunotherapy Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America Immunotherapy Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America Immunotherapy Sales, (K Units), 2017-2022
Table 41. By Country - South America Immunotherapy Sales, (K Units), 2023-2028
Table 42. By Country - Middle East & Africa Immunotherapy Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa Immunotherapy Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa Immunotherapy Sales, (K Units), 2017-2022
Table 45. By Country - Middle East & Africa Immunotherapy Sales, (K Units), 2023-2028
Table 46. Abbvie Corporate Summary
Table 47. Abbvie Immunotherapy Product Offerings
Table 48. Abbvie Immunotherapy Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 49. Amgen, Inc. Corporate Summary
Table 50. Amgen, Inc. Immunotherapy Product Offerings
Table 51. Amgen, Inc. Immunotherapy Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 52. Biogen Corporate Summary
Table 53. Biogen Immunotherapy Product Offerings
Table 54. Biogen Immunotherapy Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 55. Bristol-Myers Squibb Corporate Summary
Table 56. Bristol-Myers Squibb Immunotherapy Product Offerings
Table 57. Bristol-Myers Squibb Immunotherapy Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 58. Celgene Corporate Summary
Table 59. Celgene Immunotherapy Product Offerings
Table 60. Celgene Immunotherapy Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 61. Johnson & Johnson Corporate Summary
Table 62. Johnson & Johnson Immunotherapy Product Offerings
Table 63. Johnson & Johnson Immunotherapy Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 64. Merck Corporate Summary
Table 65. Merck Immunotherapy Product Offerings
Table 66. Merck Immunotherapy Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 67. Novartis Corporate Summary
Table 68. Novartis Immunotherapy Product Offerings
Table 69. Novartis Immunotherapy Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 70. Pfizer Corporate Summary
Table 71. Pfizer Immunotherapy Product Offerings
Table 72. Pfizer Immunotherapy Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 73. Roche Corporate Summary
Table 74. Roche Immunotherapy Product Offerings
Table 75. Roche Immunotherapy Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 76. Immunotherapy Production Capacity (K Units) of Key Manufacturers in Global Market, 2020-2022 (K Units)
Table 77. Global Immunotherapy Capacity Market Share of Key Manufacturers, 2020-2022
Table 78. Global Immunotherapy Production by Region, 2017-2022 (K Units)
Table 79. Global Immunotherapy Production by Region, 2023-2028 (K Units)
Table 80. Immunotherapy Market Opportunities & Trends in Global Market
Table 81. Immunotherapy Market Drivers in Global Market
Table 82. Immunotherapy Market Restraints in Global Market
Table 83. Immunotherapy Raw Materials
Table 84. Immunotherapy Raw Materials Suppliers in Global Market
Table 85. Typical Immunotherapy Downstream
Table 86. Immunotherapy Downstream Clients in Global Market
Table 87. Immunotherapy Distributors and Sales Agents in Global Market

List of Figures
Figure 1. Immunotherapy Segment by Type
Figure 2. Immunotherapy Segment by Application
Figure 3. Global Immunotherapy Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Immunotherapy Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Immunotherapy Revenue, 2017-2028 (US$, Mn)
Figure 7. Immunotherapy Sales in Global Market: 2017-2028 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Immunotherapy Revenue in 2021
Figure 9. By Type - Global Immunotherapy Sales Market Share, 2017-2028
Figure 10. By Type - Global Immunotherapy Revenue Market Share, 2017-2028
Figure 11. By Type - Global Immunotherapy Price (US$/Unit), 2017-2028
Figure 12. By Application - Global Immunotherapy Sales Market Share, 2017-2028
Figure 13. By Application - Global Immunotherapy Revenue Market Share, 2017-2028
Figure 14. By Application - Global Immunotherapy Price (US$/Unit), 2017-2028
Figure 15. By Region - Global Immunotherapy Sales Market Share, 2017-2028
Figure 16. By Region - Global Immunotherapy Revenue Market Share, 2017-2028
Figure 17. By Country - North America Immunotherapy Revenue Market Share, 2017-2028
Figure 18. By Country - North America Immunotherapy Sales Market Share, 2017-2028
Figure 19. US Immunotherapy Revenue, (US$, Mn), 2017-2028
Figure 20. Canada Immunotherapy Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico Immunotherapy Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe Immunotherapy Revenue Market Share, 2017-2028
Figure 23. By Country - Europe Immunotherapy Sales Market Share, 2017-2028
Figure 24. Germany Immunotherapy Revenue, (US$, Mn), 2017-2028
Figure 25. France Immunotherapy Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. Immunotherapy Revenue, (US$, Mn), 2017-2028
Figure 27. Italy Immunotherapy Revenue, (US$, Mn), 2017-2028
Figure 28. Russia Immunotherapy Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries Immunotherapy Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux Immunotherapy Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia Immunotherapy Revenue Market Share, 2017-2028
Figure 32. By Region - Asia Immunotherapy Sales Market Share, 2017-2028
Figure 33. China Immunotherapy Revenue, (US$, Mn), 2017-2028
Figure 34. Japan Immunotherapy Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea Immunotherapy Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia Immunotherapy Revenue, (US$, Mn), 2017-2028
Figure 37. India Immunotherapy Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America Immunotherapy Revenue Market Share, 2017-2028
Figure 39. By Country - South America Immunotherapy Sales Market Share, 2017-2028
Figure 40. Brazil Immunotherapy Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina Immunotherapy Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa Immunotherapy Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa Immunotherapy Sales Market Share, 2017-2028
Figure 44. Turkey Immunotherapy Revenue, (US$, Mn), 2017-2028
Figure 45. Israel Immunotherapy Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia Immunotherapy Revenue, (US$, Mn), 2017-2028
Figure 47. UAE Immunotherapy Revenue, (US$, Mn), 2017-2028
Figure 48. Global Immunotherapy Production Capacity (K Units), 2017-2028
Figure 49. The Percentage of Production Immunotherapy by Region, 2021 VS 2028
Figure 50. Immunotherapy Industry Value Chain
Figure 51. Marketing Channels

Report Title: Immunotherapy Market - Global Outlook and Forecast 2022-2028


Your Details
Valid Invalid number

SELECT A FORMAT

ADD TO CART BUY NOW

Related Report

Global Retinal Surgery Devices Market (By Device Segment, Application, Regional Analysis), Impact of COVID-19, Company Profiles, Major Deals, Strategy and Recent Developments – Forecast to 2027

Global Retinal Surgery Devices Market (By Device Segment, Application, Regional Analysis), Impact of COVID-19, Company Profiles, Major Deals, Strategy and Recent Developments – Forecast to 2027

Global Point of Care Testing (POCT) Market (By Diagnostics Segment, Mode, Platform, End Users, Region), Impact of COVID-19, Recent Developments, Company Profiles - Forecast to 2028

Global Point of Care Testing (POCT) Market (By Diagnostics Segment, Mode, Platform, End Users, Region), Impact of COVID-19, Recent Developments, Company Profiles - Forecast to 2028

Animal Wound Care Market by Product (Surgical (Sutures & Staplers, Glues), Advanced (Hydrocolloid, Hydrogel Dressings), Traditional (Tape, Dressings, Bandages), Animal Type (Cats, Dogs, Horse, Pigs), End User (Hospital, Clinics) - Global Forecast to 2027

Animal Wound Care Market by Product (Surgical (Sutures & Staplers, Glues), Advanced (Hydrocolloid, Hydrogel Dressings), Traditional (Tape, Dressings, Bandages), Animal Type (Cats, Dogs, Horse, Pigs), End User (Hospital, Clinics) - Global Forecast to 2027

Veterinary Ultrasound Market by Type (2D, 3D/4D, Doppler), Product (Portable Scanners), Technology (Contrast, Digital), Animal Type (Small, Large), Application (Gynecology, Cardiology, Orthopedics), End User (Clinics, Hospitals) - Global Forecast to 2027

Veterinary Ultrasound Market by Type (2D, 3D/4D, Doppler), Product (Portable Scanners), Technology (Contrast, Digital), Animal Type (Small, Large), Application (Gynecology, Cardiology, Orthopedics), End User (Clinics, Hospitals) - Global Forecast to 2027

Laboratory Animal Models, 3D Cultures and Organoids: Global Markets

Laboratory Animal Models, 3D Cultures and Organoids: Global Markets

Neuromodulation Market by Type (Internal (Deep Brain Stimulation, Vagus Nerve Stimulation), External (Transcranial Magnetic Stimulation)), Application (Parkinson's Disease, Depression, Urine incontinence, Epilepsy, Obesity) - Global Forecast to 2027

Neuromodulation Market by Type (Internal (Deep Brain Stimulation, Vagus Nerve Stimulation), External (Transcranial Magnetic Stimulation)), Application (Parkinson's Disease, Depression, Urine incontinence, Epilepsy, Obesity) - Global Forecast to 2027